olezarsen

Details

Key Milestones2
Call for patient/clinician input openJune 18, 2025
Call for patient/clinician input closedAugust 11, 2025
Submission receivedJuly 29, 2025
Submission accepted-

finerenone

Details

Key Milestones2
Call for patient/clinician input openJune 13, 2025
Call for patient/clinician input closedAugust 11, 2025
Submission receivedJuly 25, 2025
Submission accepted-

atezolizumab

Details

Key Milestones2
Call for patient/clinician input openJune 12, 2025
Call for patient/clinician input closedAugust 05, 2025
Submission receivedJuly 23, 2025
Clarification:

Eligible for review through the PACES process

Submission acceptedAugust 07, 2025
Review initiatedAugust 08, 2025
Draft CADTH review report(s) provided to sponsor for commentOctober 10, 2025
Deadline for sponsors commentsOctober 20, 2025
CDA-AMC review report(s) and responses to comments provided to sponsorOctober 30, 2025
Expert committee meeting (initial)November 12, 2025
Draft recommendation issued to sponsorNovember 24, 2025
To
November 26, 2025
Draft recommendation posted for stakeholder feedbackDecember 04, 2025
End of feedback periodDecember 18, 2025
Deadline for sponsor to submit redaction requests on draft CADTH review report(s)November 12, 2025

toripalimab

Details

Key Milestones2
Call for patient/clinician input openJune 10, 2025
Call for patient/clinician input closedAugust 05, 2025
Submission receivedJuly 16, 2025
Submission acceptedJuly 30, 2025
Review initiatedJuly 31, 2025
Draft CADTH review report(s) provided to sponsor for commentOctober 17, 2025
Deadline for sponsors commentsOctober 28, 2025
CDA-AMC review report(s) and responses to comments provided to sponsorNovember 21, 2025
Expert committee meeting (initial)December 03, 2025
Draft recommendation issued to sponsorDecember 15, 2025
To
December 17, 2025
Draft recommendation posted for stakeholder feedbackJanuary 02, 2026
End of feedback periodJanuary 16, 2026
Deadline for sponsor to submit redaction requests on draft CADTH review report(s)December 03, 2025

toripalimab

Details

Key Milestones2
Call for patient/clinician input openJune 10, 2025
Call for patient/clinician input closedAugust 05, 2025
Submission receivedJuly 16, 2025
Submission acceptedJuly 30, 2025
Review initiatedJuly 31, 2025
Draft CADTH review report(s) provided to sponsor for commentOctober 17, 2025
Deadline for sponsors commentsOctober 28, 2025
CDA-AMC review report(s) and responses to comments provided to sponsorNovember 21, 2025
Expert committee meeting (initial)December 03, 2025
Draft recommendation issued to sponsorDecember 15, 2025
To
December 17, 2025
Draft recommendation posted for stakeholder feedbackJanuary 02, 2026
End of feedback periodJanuary 16, 2026
Deadline for sponsor to submit redaction requests on draft CADTH review report(s)December 03, 2025